- In this section:
- Contact our Vitro Biopharma specialists
Founded in 1986, Vitro Biopharma provides ISO 9001:2015 and ISO 13485:2016–certified solutions for pharmaceutical researchers and biomedical institutions. With a focus on developing Wharton’s jelly-derived cell therapies for autoimmune diseases and inflammatory disorders, and a portfolio of cell therapies and research tools, Vitro Biopharma is committed to translating scientific research into effective medicines that transform the lives of patients.
Cambridge Bioscience is pleased to provide Vitro Biopharma products in the UK and Ireland.
Contact our Vitro Biopharma specialists to learn more about the portfolio.
